New incident report
Incident Report Number: 2021-2681
Registrant Reference Number: 2020-CA-000427
Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation
Address: 400 Plaza Drive
City: Secaucus
Prov / State: New Jersey
Country: USA
Postal Code: 07094-3688
Domestic Animal
Country: CANADA
Prov / State: ONTARIO
PMRA Registration No. 29930 PMRA Submission No. EPA Registration No.
Product Name: Hartz UltraGuard OneSpot Flea and Tick Cat Drops Spot-on
PMRA Registration No. PMRA Submission No. EPA Registration No.
Product Name: Hartz Flea Collar
Yes
Unknown
Site: Animal / Usage sur un animal domestique
Animal's Owner
Cat / Chat
Domestic Shorthair
1
Female
0.5
Unknown
Skin
>15 min <=2 hrs / >15 min <=2 h
>30 min <=2 hrs / >30 min <=2 h
System
>8 hrs <=24 hrs / > 8 h < = 24 h
No
No
Fully Recovered / Complètement rétabli
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On 22-Dec-2020, a 0.5 year old, intact female, Domestic Shorthair cat, of unknown weight, in unknown condition, with no known concomitant medical conditions, was administered 1 tube of Hartz UltraGuard OneSpot Flea and Tick Cat Drops (S Methoprene) via the topical route by the animal owner. Approximately 30 minutes after application, the cat developed hypersalivation and exhibited abnormal behaviour by lowering her body into a pouncing-like position. Approximately 1 hour after application, the cat developed lethargy and was bathed with non-insecticidal cat shampoo by the animal owner. On 23-Dec-2020, the signs resolved and the cat recovered without medical intervention. From approximately Sep-2020 to 09-Dec-2021, the cat had been wearing an unspecified Hartz flea collar that she repeatedly removed from her neck and was then reapplied by the animal owner. No further information was received.
Minor
The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.